Oak Street Health Inc (OSH) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:OSH - US67181A1079 - Common Stock
39 USD
+0.03 (+0.08%)
38.98 USD
-0.02 (-0.05%)
ChartMill assigns a Buy % Consensus number of 65% to OSH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.29. This target is -1.82% below the current price.
OSH was analyzed by 21 analysts. The buy percentage consensus is at 65. So analysts seem to be rather neutral about OSH.
In the previous month the buy percentage consensus was at a similar level.
OSH was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-21 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2023-03-15 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-02-23 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-02-15 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2023-02-10 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-02-09 | Jefferies | Downgrade | Buy -> Hold |
| 2023-02-08 | SVB Leerink | Maintains | Market Perform |
| 2023-02-08 | Stifel | Downgrade | Buy -> Hold |
| 2023-02-08 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-02-08 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-01-12 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-01-10 | SVB Leerink | Maintains | Market Perform |
| 2023-01-06 | UBS | Maintains | Neutral |
| 2022-11-21 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-11-14 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-10 | SVB Leerink | Maintains | Market Perform |
| 2022-09-12 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-08-31 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-08 | Barclays | Maintains | Overweight |
| 2022-08-04 | SVB Leerink | Maintains | Market Perform |
| 2022-08-03 | UBS | Maintains | Neutral |
| 2022-06-15 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-05-27 | Bernstein | Reiterate | Outperform |
| 2022-05-27 | Stifel | Initiate | Buy |
| 2022-04-20 | UBS | Initiate | Neutral |
| 2022-04-19 | Barclays | Maintains | Overweight |
| 2022-03-02 | SVB Leerink | Maintains | Market Perform |
| 2022-03-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-03-02 | Piper Sandler | Maintains | Overweight |
| 2022-02-22 | SVB Leerink | Maintains | Market Perform |
Oak Street Health Inc / OSH FAQ
What do analysts expect the price target to be for Oak Street Health Inc (OSH)?
21 analysts have analysed OSH and the average price target is 38.29 USD. This implies a price decrease of -1.82% is expected in the next year compared to the current price of 39.
How do analysts rate Oak Street Health Inc (OSH)?
The consensus rating for Oak Street Health Inc (OSH) is 64.7619 / 100 . This indicates that analysts generally have a neutral outlook on the stock.